Litcius/Paper detail

ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation

Shannen J. Deconinck, Christoph Nix, Svenja Barth, Eveline Bennek‐Schöpping, Antoine Rauch, An‐Sofie Schelpe, Elien Roose, Hendrik B. Feys, Inge Pareyn, Aline Vandenbulcke, Joshua Muia, Christophe Vandenbriele, Sophie Susen, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon F. De Meyer, Karen Vanhoorelbeke

2022Journal of Thrombosis and Haemostasis17 citationsDOIOpen Access PDF

Topics & Concepts

ADAMTS13Von Willebrand factorHemostasisDisintegrinThrombospondinPlateletMetalloproteinaseADAMTSProteolysisChemistryMonoclonal antibodyThrombotic thrombocytopenic purpuraMedicineImmunologyMatrix metalloproteinaseInternal medicineAntibodyBiochemistryEnzymeComplement system in diseasesPlatelet Disorders and TreatmentsMechanical Circulatory Support Devices